![Christian Itin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Itin
Algemeen Directeur bij
AUTOLUS THERAPEUTICS PLC
Vermogen: 2 M $ op 31-05-2026
Profiel
Christian Martin Itin is the founder of Zyomyx, Inc. (1998).
Dr. Itin is currently the Chief Executive Officer of Autolus Ltd. (2021), Chief Executive Officer & Director of Autolus Therapeutics Plc (2021), Director of Innate Pharma SA (2025), Director of Kymab Group Ltd. (2016), and Director of Autolus Holdings (UK) Ltd. (2018).
Former positions include Chairman, CEO & Head-Media Relations at Cytos Biotechnology AG (2012-2016), Chief Executive Officer at Micromet AG (2006), President, Chief Executive Officer & Director at Amgen Rockville, Inc. (2011-2012), Non-Executive Director at Kymab Ltd. (2012-2021), Non-Executive Director at Zyngenia, Inc. (2013-2014), and Director at Kuros Biosciences Ltd. (2018-2019).
Education includes a doctorate from the University of Basel.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 1.166.009 ( 0,7% ) | 2 M $ | 31-05-2026 |
Actieve functies van Christian Itin
| Bedrijven | Functie | Begin |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Algemeen Directeur | 01-03-2016 |
| INNATE PHARMA | Directeur/Bestuurslid | 22-05-2025 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Algemeen Directeur | 01-03-2016 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Directeur/Bestuurslid | 23-11-2016 |
Autolus Holdings (UK) Ltd.
 Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Directeur/Bestuurslid | 15-06-2018 |
Eerdere bekende functies van Christian Itin
| Bedrijven | Functie | Einde |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Directeur/Bestuurslid | 01-01-2021 |
| KUROS BIOSCIENCES AG | Voorzitter | 01-06-2018 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Algemeen Directeur | 01-01-2016 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Algemeen Directeur | 02-03-2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Christian Itin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
65
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
Zyomyx, Inc.
 Zyomyx, Inc. Medical SpecialtiesHealth Technology Designs and manufactures point-of-care diagnostic devices | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Kuros Biosciences Ltd.
 Kuros Biosciences Ltd. BiotechnologyHealth Technology Develops biological products for tissue repair | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Autolus Holdings (UK) Ltd.
Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Health Technology |
